Chase AIPricingFAQs
Display currency
Loading news…

i2o Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Allston, Massachusetts, United States Founded 2019 11-50 employees For Profit

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
13

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
39
IT spend
$220K

Company Info

Founded
2019
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
34
HQ
Allston, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
0.2
Trend (30d)
1.5
Trend (90d)
1.5
Last leadership hire
Aug 28, 2023

Acquisitions by i2o Therapeutics

Loading columns…
0 of 0Show
Page 1 / 1

Key People at i2o Therapeutics

Chairman, President & CEO
Co-Founder
13
professional contacts at i2o Therapeutics
Contact execs at i2o Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to i2o Therapeutics

Loading news…

FAQs about i2o Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
i2o Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments